| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 639518 | Cyclopentanone, 2-[[4-(benzoyloxy)-3-methoxyphenyl] methylene]-5-[(dimethylamino)methyl]-, hydrochloride | 0.0414190425892871 | 0.48663418 |
| NSC 639977 | Null | 0.0414190425892871 | 0.44575244 |
| NSC 641319 | 5,12-Naphthacenedione, 10-[[3-[[5,5-di(acetyloxy)pentyl]amino]- 2,3,6-trideoxy-.alpha.-L-lyxohexopyranosyl]oxy]- 7,8,9,10-tetrahydro-6,8,11-trihydroxy- 8-(hydroxyacetyl)-1-methoxy-, hydrochloride | 0.0414190425892871 | 0.53877324 |
| NSC 643841 | Null | 0.0414190425892871 | 0.15352451 |
| NSC 644919 | Null | 0.0414190425892871 | 0.51632023 |
| NSC 644945 | Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6-one, 5,5a,6,8,8a,9-hexahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)- 9-[2-(dimethylamino)ethoxy]-, stereoisomer, hydrochloride | 0.0414190425892871 | 0.33181525 |
| NSC 645809 | Null | 0.0414190425892871 | 0.4273746 |
| NSC 654509 | Pirarubicin HCl | 0.0414190425892871 | 0.34255138 |
| NSC 665604 | Null | 0.0414190425892871 | 0.19861361 |
| NSC 670226 | trans-2((1-(4-fluorphenyl-methyl)-4-tert.butylcyclohexyl)oxy)N,N-dimethyl-1-ethanamine-, salt with fumaric acid | 0.0414190425892871 | 0.29885155 |